Category Articles: Central Government

Non availability of Remdesivir in home care treatment of Covid19 continues

April 17, 2021

Ahmedabad: Two days ago, Amdavad Municipal Corporation (AMC) had announced that Covid patients in home care will be given Remdesivir injection through Ahmedabad Hospital and Nursing Home Association (AHNA). The AMC also supplied a stock of 450 Remdesivir injection to AHNA which were distributed immediately to doctors associated with AHNA for the use of patients. However AHNA has today informed the media that the next stock is not being supplied from AMC. According to Joint Secretaries joint ...Read More

Pharma companies reduce Remdesivir injection prices

April 17, 2021
Pharma companies reduce Remdesivir injection prices

New Delhi: Union minister Mansukh Mandaviya today announced revised prices of major brands of 'Remdesivir injection 100mg/vial'. Cadila Healthcare Ltd's Remdac continues to be the cheapest option available at Rs. 899 while Hetero Healthcare Ltd's Covifor is costliest one available at Rs. 3,490. There are total seven pharma companies that make Remdesivir injections that are in overwhelming demand due to increasing spread of Covid19 virus infection. The minister said, 'Due to Government’s interv...Read More

Nearly 10 crore Covaxin doses to be produced per month by September: Govt

April 16, 2021

New Delhi: Under Atmanirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India, to accelerate the development and production of Indigenous COVID Vaccines. This is being implemented by Department of Biotechnology Govt. of India. Under the Mission the Department of Biotechnology Govt of India is providing financial support as Grant to vaccine manufacturing facilities for enhanced production capacities. The current production capacity of indigenously developed Covaxin va...Read More

PM reviews status of oxygen availability to ensure adequate supply

April 16, 2021
PM reviews status of oxygen availability to ensure adequate supply

New Delhi: PM Narendra Modi took a comprehensive review to ensure adequate medical grade oxygen supply in the country. Inputs from ministries like Health, DPIIT, Steel, Road Transport, etc were also shared with the PM. PM stressed that it is important to ensure synergy across ministries & state governments. PM Modi also took a detailed review of current situation of oxygen supply and projected use in the coming 15 days across 12 high burden states (Maharashtra, Madhya Pradesh, Gujarat, Ut...Read More

Central Ministries, PSUs asked to dedicate their Hospital beds for Covid in States

April 16, 2021
Central Ministries, PSUs asked to dedicate their Hospital beds for Covid in States

New Delhi: The Union Health Ministry has advised all central Ministries to issue instructions to the hospitals under their control or their PSUs to set-up exclusive dedicated hospital wards or separate blocks within the hospitals for COVID Care, as was done last year. These Hospitals/Blocks should have separate entry and exit points for the management of COVID19 cases, to provide treatment services including specialised care for the confirmed COVID19 cases. Additionally, these dedicated...Read More

Mapping of 12 High Burden State to Oxygen sources initiated

April 15, 2021
Mapping of 12 High Burden State to Oxygen sources initiated

A meeting of Empowered Group 2 (EG2) was held today to review the availability of essential medical equipment and oxygen during COVID. Three important decisions taken today are as explained below. i. Mapping of oxygen sources for 12 high burden states - Medical oxygen is a critical component in the treatment of COVID affected patients. There has been increasing demand for medical oxygen, especially from the 12 states with high burden of active COVID cases viz.– Maharashtra, Madhya Pradesh, ...Read More

Remdesivir manufacturing to increase, price to go down: Mandaviya

April 14, 2021
Remdesivir manufacturing to increase, price to go down: Mandaviya

New Delhi: The Government of India has decided to increase the production and supply of Remdesivir drug and reduce its prices. Thanks to this decision, production capacity for manufacturing will ramp up to around 80 lakh vials per month. Manufacturers of Remdesivir are also going to reduce the price to less than Rs 3500 by the end of this week. These details were shared by union minister Mansukh Mandaviya. The issue of availability of Remdesivir was reviewed by minister Mansukh Mandaviya in ...Read More

CBSE exams of class 12 postponed, class 10 cancelled: Pokhriyal

April 14, 2021
CBSE exams of class 12 postponed, class 10 cancelled: Pokhriyal

New Delhi: Union Education minister Dr. Ramesh Pokhriyal Nishank today announced that CBSE Board Exams for Class XIIth to be held from May 4th to June, 14th, 2021 are postponed. These exams will be held hereafter. The situation will be reviewed on 1st June 2021 by the Board, and details will be shared subsequently. A notice of at least 15 days will be given before the start of the examinations. The Board Exams for Class Xth to be held from 4th May to June 14th, 2021 are cancelled. The result...Read More

Gujarat govt proposes Centre to start 900-bed DRDO hospital in Ahmedabad; CM announces new Covid related restrictions

April 12, 2021
Gujarat govt proposes Centre to start 900-bed DRDO hospital in Ahmedabad; CM announces new Covid related restrictions

Gandhinagar: Gujarat Chief Minister Vijay Rupani today said that the State government has urged the Centre to start DRDO covid hospital at GMDC ground based community hall. The Chief Minister while addressing the people through social media via video said that such hospital will have oxygen facility and it will have 900 beds. The Chief Minister said that with effect from April 14, maximum only 50 persons will be allowed to attend wedding functions. He announced ban on all kinds of public fun...Read More

Govt of India bans exports of Remdesivir injections

April 11, 2021
Govt of India bans exports of Remdesivir injections

New Delhi: The Government of India has suspended exports of anti-viral drug Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) amid its high demand due to rising Covid-19 cases. Seven Indian companies produce Remdesivir injections under a voluntary licensing agreement with Amrican company Gilead Sciences, with an installed capacity of around 38.80 lakh units/month. “India is witnessing a recent surge in COVID cases. As on 11.04.2021, there are 11.08 lakh active COVID cases an...Read More

error: Content is protected !!